RRM1 and gastric cancer: Meanwhile, RRM1 expression has been shown to be a powerful predictor of survival or chemotherapy susceptibility in patients with carcinomas, such as pancreatic cancer 23, advanced nasopharyngeal carcinoma 24, and gastric cancer 25, treated with adjuvant gemcitabine‐based chemotherapy.